Revolutionizing Heart Health: Preventing Heart Attacks with SCAPIS
Every year, approximately 8,000 individuals under the age of 70 experience their first heart attack, with over 1,000 losing their lives to this preventable condition. In an effort to combat this alarming statistic, Göran Bergström, chief physician at Sahlgrenska University Hospital in Gothenburg, has ambitious goals for reducing heart attack risk by the year 2030.
Dr. Bergström leads SCAPIS (Swedish CardioPulmonary bioImage Study), the largest study of its kind globally, which focuses on heart, blood vessel, and lung health. This initiative, a collaboration of six universities and university hospitals, involves examining 30,000 residents to enhance our understanding of how to predict and prevent heart and lung diseases over time.
His primary aim is to identify seemingly healthy individuals who are at risk for heart attacks, even if they exhibit no symptoms. "I truly want to find tools to identify those individuals," said Bergström. The SCAPIS study is crucial in shedding light on this critical area of health.
The findings from SCAPIS have been eye-opening. More than 40% of participants exhibited changes in their heart’s blood vessels indicative of a heart attack risk. While most of these changes were minor, around one in twenty individuals had significant changes unbeknownst to them. The challenge now is to develop more cost-effective techniques, including simple blood tests, to identify these at-risk individuals.
"If we can find them, we can provide preventive assistance to ensure they do not have to suffer a heart attack," Bergström explained. The preventive measures encompass lifestyle modifications, but advancements in medication also play a vital role. The goal is to harness these tools effectively once individuals at risk have been identified.
What could truly revolutionize heart health is the potential development of simple yet advanced methods to identify high-risk individuals. A straightforward blood measurement test could drastically change the approach to heart health. "If SCAPIS can develop an effective and economical screening method, I aim to reduce the number of people in the high-risk zone by 30% by 2030," Bergström stated.
However, the financial aspect cannot be overlooked. The extensive nature of the SCAPIS study requires significant funding, primarily provided by the HeartLung Foundation. To push forward with this vital research, every penny counts.
"We can measure a variety of things in the blood of these individuals, but we still cannot afford to measure everything we desire," Bergström noted. He remains optimistic, citing that soon, innovative solutions will emerge, but continued funding is essential to make those advancements a reality.
As the research progresses, contributions from the public can make a significant difference in stopping heart attacks before they occur, creating a healthier future for many.
Related Sources: